On the 23rd, SK Bioscience publicly announced that the manufacture and supply of its self-developed COVID-19 vaccine ‘SKYCovione’ have currently been discontinued.

SK Bioscience received marketing authorization for SKYCovione in Korea in July this year. In September, the company supplied an initial batch of 60 thousand doses of the 10 million doses that the government pre-purchased through an agreement.

However, further manufacture and supply of the vaccine have been discontinued. One reason is that the overall vaccination rate has fallen with the slowdown of the COVID-19 outbreak and the increasing number of people with immunity.

According to the Korea Disease Control